HC Wainwright resumed coverage on Chiasma with a new price target
$CHMA
Major Pharmaceuticals
Health Care
HC Wainwright resumed coverage of Chiasma with a rating of Buy and set a new price target of $12.00 from $10.00 previously
Save time and jump to the most important pieces.
Jefferies downgraded Chiasma from Buy to Hold
HC Wainwright resumed coverage of Chiasma with a rating of Buy and set a new price target of $12.00 from $10.00 previously
4 - CHIASMA, INC (0001339469) (Issuer)
4 - CHIASMA, INC (0001339469) (Issuer)
4 - CHIASMA, INC (0001339469) (Issuer)